Rvl Pharmaceuticals Plc (RVLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -79,589 | -37,223 | -16,082 | -3,083 | -270,901 |
| Depreciation Amortization | 94,478 | 39,746 | 406 | 5,562 | 340,762 |
| Income taxes - deferred | -1,156 | -974 | 682 | 829 | -26,794 |
| Accounts receivable | 17,496 | 22,339 | -370 | 11,242 | 12,674 |
| Accounts payable and accrued liabilities | -1,723 | -586 | -523 | 289 | -16,375 |
| Other Working Capital | -1,857 | 6,181 | -4,435 | -4,838 | -15,778 |
| Other Operating Activity | -10,059 | -3,641 | 36,623 | -10,065 | 9,979 |
| Operating Cash Flow | $17,590 | $25,842 | $16,301 | $-64 | $33,567 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,134 | -2,163 | -1,542 | -945 | -3,946 |
| Net Acquisitions | 50 | -209 | -138 | -1 | -74 |
| Investing Cash Flow | $-3,084 | $-2,372 | $-1,680 | $-946 | $-4,020 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,314 |
| Debt Repayment | -50,127 | -50,098 | -66 | -33 | -3,218 |
| Common Stock Issued | 62,659 | 62,440 | 31,791 | 31,791 | N/A |
| Common Stock Repurchased | -8,101 | -4,835 | -1,086 | -167 | -2,787 |
| Other Financing Activity | -749 | -749 | -749 | -616 | 0 |
| Financing Cash Flow | $3,682 | $6,758 | $29,890 | $30,975 | $-4,691 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 175 |
| Beginning Cash Position | 95,865 | 95,865 | 95,865 | 95,865 | 70,834 |
| End Cash Position | 114,053 | 126,093 | 140,376 | 125,830 | 95,865 |
| Net Cash Flow | $18,188 | $30,228 | $44,511 | $29,965 | $25,031 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,590 | 25,842 | 16,301 | -64 | 33,567 |
| Capital Expenditure | -2,920 | -2,213 | -1,591 | -949 | -3,963 |
| Free Cash Flow | 14,670 | 23,629 | 14,710 | -1,013 | 29,604 |